Lenvima
Lenvima is the brand name for lenvatinib, a targeted therapy medication used to treat certain types of cancer. It is an oral tyrosine kinase inhibitor, meaning it works by blocking specific enzymes that cancer cells need to grow and divide. Lenvima is primarily used in combination with other drugs to treat advanced or metastatic thyroid cancer that has not responded to radioactive iodine treatment. It is also used in combination with other therapies for advanced renal cell carcinoma (kidney cancer) and unresectable hepatocellular carcinoma (liver cancer).
The mechanism of action of Lenvima involves inhibiting multiple receptor tyrosine kinases, including those for vascular
Common side effects of Lenvima can include fatigue, diarrhea, hypertension (high blood pressure), decreased appetite, weight